---
title: "TVTX.US (TVTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TVTX.US/news.md"
symbol: "TVTX.US"
name: "TVTX.US"
parent: "https://longbridge.com/en/quote/TVTX.US.md"
datetime: "2026-03-16T04:55:01.182Z"
locales:
  - [en](https://longbridge.com/en/quote/TVTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TVTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TVTX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/TVTX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TVTX.US/news.md)


# TVTX.US (TVTX.US) — Related News

### [How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall](https://longbridge.com/en/news/278951390.md)
*2026-03-12T22:26:19.000Z*
> Travere Therapeutics reported strong Q4 and full-year results, driven by FILSPARI sales, and anticipates a $25 million m

### [Travere Therapeutics, Inc. (NASDAQ:TVTX) Given Average Rating of "Moderate Buy" by Analysts](https://longbridge.com/en/news/277279409.md)
*2026-02-28T06:58:07.000Z*
> Travere Therapeutics, Inc. (NASDAQ:TVTX) has received an average rating of "Moderate Buy" from fourteen analysts. Among 

### [Travere Therapeutics (NASDAQ:TVTX)  Shares Down 5.4%   - Should You Sell?](https://longbridge.com/en/news/276475640.md)
*2026-02-20T18:40:18.000Z*
> Travere Therapeutics (NASDAQ:TVTX) shares fell 5.4% to $27.7250, with trading volume down 92% from average levels. Analy

### [](https://longbridge.com/en/news/276345160.md)
*2026-02-19T14:22:02.000Z*
> Pediatrix Medical Group shares are trading lower after the company reported mixed Q4 financial results.

### [Travere Therapeutics | 8-K: FY2025 Revenue Misses Estimate at USD 490.73 M](https://longbridge.com/en/news/276377724.md)
*2026-02-19T21:07:51.000Z*
### [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://longbridge.com/en/news/276330067.md)
*2026-02-19T12:05:42.000Z*
> In Thursday's pre-market session, Anebulo Pharmaceuticals (ANEB) shares rose 13.4% to $0.56, while Lunai Bioworks (LNAI)

### [Travere Therapeutics Q4 Earnings Report: What Investors Need to Know](https://longbridge.com/en/news/276377550.md)
*2026-02-19T21:04:41.000Z*
> Travere Therapeutics (NASDAQ:TVTX) reported Q4 earnings on February 19, 2026, beating estimates by 54.17% with an EPS of

### [Earnings Outlook For Travere Therapeutics](https://longbridge.com/en/news/276254104.md)
*2026-02-18T17:01:22.000Z*
> Travere Therapeutics (NASDAQ:TVTX) is set to release its quarterly earnings report on February 19, 2026, with analysts e